Download PDF
Thromb Haemost 1997; 77(05): 0981-0985
DOI: 10.1055/s-0038-1656089
Platelets
Schattauer GmbH Stuttgart

The Integrin α2β1 (GPIa/IIa)-I-Domain Inhibits Platelet-Collagen Interaction

H Depraetere
1   The Laboratory for Thrombosis Research, Interdisciplinary Research Center, K. U. Leuven, Campus Kortrijk, Belgium
,
C Wille
1   The Laboratory for Thrombosis Research, Interdisciplinary Research Center, K. U. Leuven, Campus Kortrijk, Belgium
2   The Provinciale Industriële Hogeschool (PIH), Kortrijk, Belgium
,
Y Gansemans
3   The Corvas International NV, Gent, Belgium
,
P Stanssens
3   The Corvas International NV, Gent, Belgium
,
M Lauwereys
3   The Corvas International NV, Gent, Belgium
,
D Baruch
4   INSERMU143, Paris, France
,
S De Reys
1   The Laboratory for Thrombosis Research, Interdisciplinary Research Center, K. U. Leuven, Campus Kortrijk, Belgium
,
H Deckmyn
1   The Laboratory for Thrombosis Research, Interdisciplinary Research Center, K. U. Leuven, Campus Kortrijk, Belgium
› Author Affiliations
Further Information

Publication History

Received 19 July 1996

Accepted after resubmission 15 January 1997

Publication Date:
11 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

The integrin α2β1 is a major cellular receptor for collagen. The α2subunit contains an ± 200 amino acids inserted domain (I-domain) in the N-terminal region. A certain degree of homology exists between the I-domains found in integrins, collagen and the A-domains of vWF.

The α2-I-domain encoding region (aa residues D145 to S334) was obtained by RT-PCR from mRNA of non stimulated human PBL’s. The primers were designed to introduce the necessary restriction sites for cloning of the DNA fragment in frame downstream of the malE gene, as well as a stop codon after the last triplet. The resulting construct pMAL-c2-α2-I allows the expression of the I-domain, fused to the C-terminus of maltose binding protein (mal). The α2-I-mal is purified from the bacterial extract by affinity chromatography on an amylose column.

The purified α2-I-mal has been characterized by ELISA’s. The animal bound to immobilised collagen type I in a concentration dependent manner and could be blocked by the functional monoclonal anti-α2β1 antibody 6F1.

The interaction of α2-I-mal with collagen furthermore is Mg2+- dependent since the binding was inhibited in the presence of 10 mM EDTA or 10 mM Ca2+ but sustained in the presence of 10 mM Mg2+.

Finally, α2-I-mal itself was able to inhibit adhesion of washed platelets to collagen immobilised on a microtiterplate in a dose-dependent manner (α2-I-mal IC50:0.7 μ M) as well as platelet aggregation induced by collagen type I (α2-I-mal IC50: 0.7 μM).

With these results we could confirm that the α2-I-domain represents the collagen-binding site of α2β1 and we furthermore could indicate that this domain is able to prevent platelet adhesion to collagen and collagen-induced platelet aggregation, pointing to the primordial role of α2-I-mal and hence of α2β1 in platelet-collagen interaction.

 

  • References

  • 1 Santoro SA. Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen. Cell 1986; 46: 913-920
    CrossrefPubMedGoogle Scholar
  • 2 Nieuwenhuis HK, Akkerman JW, Houdijk WP, Sixma JJ. Human blood platelets showing no response to collagen fail to express surface glycoprotein la. Nature 1985; 318: 470-472
    CrossrefPubMedGoogle Scholar
  • 3 Sixma JJ. Platelet adhesion in health and disease. In: Thrombosis and Haemostasis. Verstraete M, Vermylen J, Lijnen HR, Amout J. eds. Leuven University Press; 1987. pp 127-146
    Google Scholar
  • 4 Saelman EU, Nieuwenhuis HK, Hese KM, de Groot PG, Heijnen HF, Sage EH, Williams S, McKeown L, Gralnick HR, Sixma JJ. Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (alpha 2 beta 1-integrin). Blood 1994; 83: 1244-1250
    PubMedGoogle Scholar
  • 5 Sixma JJ, de Groot PG. von Willebrand factor and the blood vessel wall. Mayo ClinProc 1991; 66: 628-633
    PubMedGoogle Scholar
  • 6 Goto S, Salomon DR, Ikeda Y, Ruggeri ZM. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem 1995; 270: 23352-23361
    CrossrefPubMedGoogle Scholar
  • 7 Zutter MM, Santoro SA. Widespread histologic distribution of the alpha 2 beta 1 integrin cell-surface collagen receptor. Am J Pathol 1990; 137: 113-120
    PubMedGoogle Scholar
  • 8 Ellis SG, Tcheng JE, Navetta FI, Muller DW, Weisman HF, Smith C, Anderson KM, Califf RM, Topol EJ. Safety and antiplatelet effect of murine monoclonal antibody 7E3 Fab directed against platelet glycoprotein Ilb/IIIa in patients undergoing elective coronary angioplasty. Coron Artery Dis 1993; 4: 167-175
    CrossrefPubMedGoogle Scholar
  • 9 Languino LR, Gehlsen KR, Wayner E, Carter WG, Engvall E, Ruoslahti E. Endothelial cells use alpha 2 beta 1 integrin as a laminin receptor. J Cell Biol 1989; 109: 2455-2462
    CrossrefPubMedGoogle Scholar
  • 10 Kirchhofer D, Languino LR, Ruoslahti E, Pierschbacher MD. Alpha 2 beta 1 integrins from different cell types show different binding specificities. J Biol Chem 1990; 265: 615-618
    PubMedGoogle Scholar
  • 11 Bergelson JM, Shepley MP, Chan BM, Hemler ME, Finberg RW. Identification of the integrin VLA-2 as a receptor for echo virus 1. Science 1992; 255: 1718-1720
    CrossrefPubMedGoogle Scholar
  • 12 Bergelson JM, Chan BM, Finberg RW, Hemler ME. The integrin VLA-2 binds echo virus 1 and extracellular matrix ligands by different mechanisms. J Clin Invest 1993; 92: 232-239
    CrossrefPubMedGoogle Scholar
  • 13 Santoro SA, Zutter MM. The alpha-2 beta-1 integrin: a collagen receptor on platelets and other cells. Thromb Haemost 1995; 74: 813-821
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Lee JO, Rieu P, Amaout MA, Liddington R. Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD1 lb/CD 18). Cell 1995; 80: 631-638
    CrossrefPubMedGoogle Scholar
  • 15 Kehrel B, Balleisen L, Kokott R, Mesters R, Stenzinger W, Clemetson KJ, van de LooJ. Deficiency of intact thrombospondin and membrane glycoprotein la in platelets with defective collagen-induced aggregation and spontaneous loss of disorder. Blood 1988; 71: 1074-1078
    PubMedGoogle Scholar
  • 16 Handa M, Watanabe K, Kawai Y, Kamata T, Koyama T, Nagai H, Ikeda Y. Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder. Thromb Haemost 1995; 73: 521-528
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Deckmyn H, Chew SL, Vermylen J. Lack of platelet response to collagen associated with an autoantibody against glycoprotein la: a novel cause of acquired qualitative platelet dysfunction. Thromb Haemost 1990; 64: 74-79
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Deckmyn H, Zhang J, Van HoutteE, Vermylen J. Production and nucleotide sequence of an inhibitory human IgM autoantibody directed against platelet glycoprotein Ia/IIa. Blood 1994; 84: 1968-1974
    PubMedGoogle Scholar
  • 19 Kamata T, Puzon W, Takada Y. Identification of putative ligand binding sites within I domain of integrin alpha 2 beta 1 (VLA-2, CD49b/CD29). J Biol Chem 1994; 269: 9659-9663
    PubMedGoogle Scholar
  • 20 Kamata T, Takada Y. Direct binding of collagen to the I domain of integrin alpha 2 beta 1 (VLA-2, CD49b/CD29) in a divalent cation-independent manner. J Biol Chem 1994; 269: 26006-26010
    PubMedGoogle Scholar
  • 21 Bahou WF, Potter CL, Mirza H. The VLA-2 (alpha 2 beta 1) I domain functions as a ligand-specific recognition sequence for endothelial cell attachment and spreading: molecular and functional characterization. Blood 1994; 84: 3734-3741
    PubMedGoogle Scholar
  • 22 Colombatti A, Bonaldo P. The superfamily of proteins with von Willebrand factor type A-like domains: one theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms. Blood 1991; 77: 2305-2315
    PubMedGoogle Scholar
  • 23 Coller BS, Beer JH, Scudder LE, Steinberg MH. Collagen-platelet interactions: evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb/IIIa mediated by adhesive proteins. Blood 1989; 74: 182-192
    PubMedGoogle Scholar
  • 24 Deckmyn H, Stassen JM, Vreys I, Van HoutteE, Sawyer RT, Vermylen J. Calin from Hirudo medicinalis, an inhibitor of platelet adhesion to collagen, prevents platelet-rich thrombosis in hamsters. Blood 1995; 85: 712-719
    PubMedGoogle Scholar
  • 25 Konstantopoulos K, Wu KK, Udden MM, Banez El, Shattil SJ, Heliums JD. Flow cytometric studies of platelet responses to shear stress in whole blood. Biorheology 1995; 32: 73-93
    CrossrefPubMedGoogle Scholar
  • 26 Takada Y, Hemler ME. The primary structure of the VLA-2/collagen receptor alpha 2 subunit (platelet GPIa): homology to other integrins and the presence of a possible collagen-binding domain. J Cell Biol 1989; 109: 397-407
    CrossrefPubMedGoogle Scholar
  • 27 De ReysS, Hoylaerts MF, De Ley M, Vermylen J, Deckmyn H. Fc-inde- pendent cross-linking of a novel platelet membrane protein by a monoclonal antibody causes platelet activation. Blood 1994; 84: 547-555
    PubMedGoogle Scholar
  • 28 Tuckwell D, Calderwood DA, Green LJ, Humphries MJ. Integrin alpha 2 I-domain is a binding site for collagens. J Cell Sci 1995; 108: 1629-1637
    PubMedGoogle Scholar